SCHEMBL6164828

SCHEMBL6164828

CC(=O)CC1CC(=O)N(Cc2ccc(Oc3ccccc3)cc2)C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 2/20 0.53
ALOX5 P09917 2/20 0.53
ALDH1A1 P00352 4/20 0.45
GAA P10253 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
STAT6 P42226 1/20 0.45
TSHR P16473 3/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
HCRTR1 O43613 3/20 0.42
HCRTR2 O43614 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6160115 0.81 SMN1; SMN2 (0.47) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6158601 0.80 ALDH1A1 (0.48) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL7082507 0.77 ALDH1A1 (0.48) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6157379 0.77 ALDH1A1 (0.48) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6157032 0.76 ALDH1A1 (0.54) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6159152 0.75 ALDH1A1 (0.50) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6158480 0.74 ALDH1A1 (0.47) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL14825139 0.74 MEN1 (0.67) ALDH1A1GAATSHRKMT2AMEN1
SCHEMBL14567087 0.74 ALDH1A1 (0.48) MT-CO2ALOX5ALDH1A1GAACYP1A2
SCHEMBL6158680 0.74 HCRTR1 (0.46) MT-CO2ALOX5ALDH1A1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 MT-CO2 145/4885ALOX5 231/4885ALDH1A1 905/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 MT-CO2 146/4885ALOX5 201/4885ALDH1A1 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.